CHOP [cyclophosphamide, doxorubicin, vincristine, prednisone]/rituximab followed by maintenance pegylated interferon-alpha [peginterferon-alfa-2b] (PEG Intron) with the treatment of patients with anthracycline naïve indolent/follicular non-Hodgkin's lymphoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cyclophosphamide; Doxorubicin; Peginterferon alfa-2b; Prednisone; Rituximab; Vincristine
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 24 Jan 2018 Biomarkers information updated
- 08 Jan 2008 New trial record.